Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on Invested CapitalReturn on Sales

Dr Reddys Laboratories (RDY) Net Margin (2016 - 2025)

Historic Net Margin for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to 13.86%.

  • Dr Reddys Laboratories' Net Margin fell 30500.0% to 13.86% in Q4 2025 from the same period last year, while for Dec 2025 it was 10.84%, marking a year-over-year decrease of 61200.0%. This contributed to the annual value of 17.4% for FY2025, which is 26800.0% down from last year.
  • As of Q4 2025, Dr Reddys Laboratories' Net Margin stood at 13.86%, which was down 30500.0% from 18.74% recorded in Q1 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Net Margin peaked at 22.78% during Q1 2022, and registered a low of 0.0% during Q3 2022.
  • Over the past 5 years, Dr Reddys Laboratories' median Net Margin value was 17.16% (recorded in 2021), while the average stood at 15.75%.
  • Per our database at Business Quant, Dr Reddys Laboratories' Net Margin plummeted by -132700bps in 2022 and then soared by 215100bps in 2023.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Net Margin stood at 1.6% in 2021, then skyrocketed by 853bps to 15.23% in 2022, then grew by 25bps to 19.11% in 2023, then decreased by -12bps to 16.91% in 2024, then decreased by -18bps to 13.86% in 2025.
  • Its Net Margin was 13.86% in Q4 2025, compared to 18.74% in Q1 2025 and 16.91% in Q4 2024.